Unlocking the Genetic Code: Harnessing the Power of Human Genotyping Arrays for Accurate Polygenic Risk Score Analysis

Join us for an insightful webinar on the use of polygenic risk scores (PRS) for cardiovascular disease (CVD). The analysis of genetic variation across large populations plays a crucial role in scientific and clinical advancements. Microarray technologies have proven to be instrumental in these efforts, allowing for the simultaneous analysis of hundreds of thousands to millions of genetic variants in a single assay.

 

During this webinar, we will showcase the power and utility of microarrays in predictive genomics applications, specifically focusing on polygenic risk scoring for cardiovascular disease. We will highlight the importance of robust PRS reporting solutions that provide personalized risk assessments, ultimately improving health outcomes and facilitating effective health management for various common diseases.

 

Dr. Anuradha Mittal, a senior staff scientist in Bioinformatics at Thermo Fisher Scientific, will present on the topic of microarrays for cardiovascular disease testing and the valuable insights PRS provides for these complex diseases. Following the presentation, our esteemed panel of speakers will engage in a discussion exploring the future and challenges of PRS for CVD and beyond.

 

The panel includes Shantanu Kaushikkar, MBA, Director of Microarray Business Development at Thermo Fisher Scientific, Giordano Bottà, PhD, CEO & Co-Founder of Allelica, and Paul Lacaze, PhD, Head of Genomics at the Victorian Heart Institute, Monash University. Together, they will discuss the challenges and solutions associated with microarray technology for population-scale testing, with a specific focus on the use of polygenic risk scores for critical health concerns like cardiovascular disease.

 

This webinar promises to provide valuable insights into the application of microarrays in genomics research and their potential impact on predicting disease risk across diverse populations. Don't miss this opportunity to learn from experts in the field and gain valuable insights into the application of microarrays in advancing genomic analysis, the role of polygenic risk scores (PRS) in predicting disease risk, and the benefits of personalized PRS reporting solutions.

 

Learning Objectives

This webinar is for: